Literature DB >> 16270279

Oxidized phospholipids as triggers of inflammation in atherosclerosis.

Norbert Leitinger1.   

Abstract

Chronic inflammatory diseases including atherosclerosis are major causes of morbidity and mortality worldwide. However, the factors, which trigger processes that determine the outcome of an inflammatory response, are still poorly understood. Accumulating evidence suggests that certain lipid oxidation products, such as oxidized phospholipids (OxPL), may represent endogenously formed factors that are capable of triggering vascular inflammation. This review will address important questions regarding mechanisms involved in acute and chronic inflammation, and discuss the role of OxPL as key players in triggering the inflammatory response in atherosclerosis. Better understanding of how OxPL contribute to vascular inflammation should lead to new strategies in the treatment of chronic inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16270279     DOI: 10.1002/mnfr.200500086

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  22 in total

1.  Lysophosphatidic acid effects on atherosclerosis and thrombosis.

Authors:  Mei-Zhen Cui
Journal:  Clin Lipidol       Date:  2011-08

2.  Host derived inflammatory phospholipids regulate rahU (PA0122) gene, protein, and biofilm formation in Pseudomonas aeruginosa.

Authors:  Jayasimha Rao; Antonio DiGiandomenico; Mykhaylo Artamonov; Norbert Leitinger; Ashok R Amin; Joanna B Goldberg
Journal:  Cell Immunol       Date:  2011-05-05       Impact factor: 4.868

Review 3.  Oxidized lipids: the two faces of vascular inflammation.

Authors:  Konstantin G Birukov
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

4.  Fibroblast growth factor 21 attenuates inflammation and oxidative stress in atherosclerotic rat via enhancing the Nrf1-ARE signaling pathway.

Authors:  Haizhen Jia; Jing Cheng; Qi Zhou; Jun Peng; Yunhong Pan; Hongyan Han
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

5.  Oxidatively modified low density lipoprotein (LDL) inhibits TLR2 and TLR4 cytokine responses in human monocytes but not in macrophages.

Authors:  Yashaswini Kannan; Kruthika Sundaram; Chandrakala Aluganti Narasimhulu; Sampath Parthasarathy; Mark D Wewers
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

6.  Evidence for the importance of OxPAPC interaction with cysteines in regulating endothelial cell function.

Authors:  James R Springstead; B Gabriel Gugiu; Sangderk Lee; Seung Cha; Andrew D Watson; Judith A Berliner
Journal:  J Lipid Res       Date:  2012-05-01       Impact factor: 5.922

7.  ATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response.

Authors:  Olga V Oskolkova; Taras Afonyushkin; Alexander Leitner; Elena von Schlieffen; Peter S Gargalovic; Aldons J Lusis; Bernd R Binder; Valery N Bochkov
Journal:  Blood       Date:  2008-05-01       Impact factor: 22.113

8.  Oxidized phospholipid species promote in vivo differential cx43 phosphorylation and vascular smooth muscle cell proliferation.

Authors:  Scott R Johnstone; Jeremy Ross; Michael J Rizzo; Adam C Straub; Paul D Lampe; Norbert Leitinger; Brant E Isakson
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

9.  The role of oxidized phospholipids in atherosclerosis.

Authors:  Judith A Berliner; Norbert Leitinger; Sotirios Tsimikas
Journal:  J Lipid Res       Date:  2008-12-04       Impact factor: 5.922

10.  Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration.

Authors:  Mihoko Suzuki; Motohiro Kamei; Hiroyuki Itabe; Kazuhito Yoneda; Hajime Bando; Noriaki Kume; Yasuo Tano
Journal:  Mol Vis       Date:  2007-05-23       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.